title: Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls.
abstract: BACKGROUND
  Polycystic ovarian syndrome (PCOS) is associated with cardiovascular risk factors (CRF). Lifestyle intervention is regarded as therapy of choice even if studies in adolescent girls with PCOS are scarce.
  
  
  OBJECTIVE
  Our objective was to analyze the impact of lifestyle intervention on menses irregularities, hyperandrogenemia, CRF, and intima-media thickness (IMT) in adolescent girls with PCOS.
  
  
  METHODS
  Patients included 59 obese girls with PCOS aged 12-18 yr.
  
  
  METHODS
  Intervention was a 1-yr lifestyle intervention based on nutrition education, exercise training, and behavior therapy.
  
  
  METHODS
  Menses cycles, IMT, waist circumference, blood pressure, fasting lipids, insulin, glucose, testosterone, dehydroepiandrosterone sulfate, androstenedione, and SHBG were evaluated.
  
  
  RESULTS
  In contrast to the 33 girls without weight loss, the 26 girls reducing their body mass index during the lifestyle intervention (by a mean of -3.9 kg/m(2)) improved most CRF and decreased their IMT (by a mean of -0.01 cm). Testosterone concentrations decreased (by a mean of -0.3 nmol/liter) and SHBG concentrations increased (by a mean of +8 ng/ml) significantly in girls with weight loss in contrast to girls with increasing weight. The prevalence of amenorrhea (-42%) and oligoamenorrhea (-19%) decreased in the girls with weight loss. The changes in insulin in the 1-yr follow-up were significantly correlated to changes in testosterone (r = 0.38; P = 0.002) and SHBG (r = -0.35; P = 0.048). A linear regression model with changes in IMT as dependent variable demonstrated a significant association with changes in blood pressure and weight status but not with changes in testosterone.
  
  
  CONCLUSIONS
  Weight loss due to lifestyle intervention is effective to treat menses irregularities, normalize androgens, and improve CRF and IMT in obese adolescent girls with PCOS.
authors: Department of Pediatric Endocrinology, Diabetes, and Nutrition Medicine, Vestische Hospital for Children and Adolescents, University of Witten/Herdecke, Dr. F. Steiner Strasse 5, D-45711 Datteln, Germany.
authors: Nina
authors: N
authors: Lass
authors: Michaela
authors: M
authors: Kleber
authors: Katrin
authors: K
authors: Winkel
authors: Rainer
authors: R
authors: Wunsch
authors: Thomas
authors: T
authors: Reinehr
mesh_terms: D000293:Adolescent; D001823:Body Composition / Q000502:physiology; D015992:Body Mass Index; D059168:Carotid Intima-Media Thickness; D002648:Child; D005081:Exercise Therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005500:Follow-Up Studies; D006801:Humans; D008019:Life Style; D007986:Luteinizing Hormone / Q000097:blood; D024821:Metabolic Syndrome / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D009765:Obesity / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D013739:Testosterone / Q000097:blood; D016896:Treatment Outcome; D055105:Waist Circumference; D015431:Weight Loss
chemical_list: D013739:Testosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone